SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BISCAGLIA, Simone
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.365
AS - Asia 1.385
EU - Europa 1.298
OC - Oceania 26
AF - Africa 17
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.106
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.327
CN - Cina 571
SG - Singapore 358
IT - Italia 333
TR - Turchia 159
GB - Regno Unito 158
DE - Germania 148
PL - Polonia 135
UA - Ucraina 125
FR - Francia 122
SE - Svezia 118
ID - Indonesia 99
FI - Finlandia 63
CA - Canada 35
VN - Vietnam 34
IN - India 32
BE - Belgio 31
HK - Hong Kong 28
KR - Corea 26
AU - Australia 25
JP - Giappone 15
EG - Egitto 13
IR - Iran 11
LT - Lituania 11
MY - Malesia 11
BR - Brasile 10
CZ - Repubblica Ceca 10
TH - Thailandia 8
PK - Pakistan 7
RU - Federazione Russa 7
ES - Italia 6
TW - Taiwan 6
CY - Cipro 5
IQ - Iraq 5
PT - Portogallo 5
CH - Svizzera 4
KE - Kenya 3
LI - Liechtenstein 3
RO - Romania 3
DK - Danimarca 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
IE - Irlanda 2
IL - Israele 2
MK - Macedonia 2
MX - Messico 2
NO - Norvegia 2
PS - Palestinian Territory 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
CO - Colombia 1
ET - Etiopia 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
SI - Slovenia 1
VE - Venezuela 1
Totale 8.106
Salva come PNG Salva come JPEG
Città #
Fairfield 754
Woodbridge 562
Ashburn 466
Houston 418
Chandler 331
Seattle 303
Ann Arbor 298
Wilmington 288
Singapore 281
Cambridge 265
Santa Clara 257
Jacksonville 181
Beijing 133
Warsaw 130
Izmir 93
Princeton 93
New York 88
Shanghai 85
Nanjing 82
Jakarta 78
Ferrara 69
Milan 65
San Diego 62
Los Angeles 39
Brussels 31
London 31
Boardman 30
Helsinki 29
Bremen 28
Falls Church 28
Nanchang 22
Redwood City 19
Shenyang 17
Frankfurt am Main 16
Norwalk 16
Tianjin 16
Toronto 16
Dong Ket 15
Hong Kong 15
Jiaxing 15
Melbourne 15
Changsha 14
Hebei 14
Munich 14
Chicago 13
Mumbai 13
Des Moines 12
Washington 12
Addison 11
Bologna 11
Augusta 10
Ottawa 10
Mountain View 9
Redmond 9
Bangkok 8
Brno 8
Chennai 8
San Mateo 8
Tokyo 8
Rome 7
Cairo 6
Guangzhou 6
Hounslow 6
Jinan 6
Ningbo 6
Parma 6
Songpa-gu 6
Auburn Hills 5
Dearborn 5
Detroit 5
Kunming 5
Lappeenranta 5
Nicosia 5
Rimini 5
Tappahannock 5
Bandung 4
Changchun 4
Monmouth Junction 4
Orange 4
Perth 4
Pontianak 4
Senigallia 4
Tanta 4
Tehran 4
Yogyakarta 4
Aveiro 3
Bari 3
Camerino 3
Cincinnati 3
Duncan 3
Ferrara di Monte Baldo 3
Foglianise 3
Gurugram 3
Jonzieux 3
Kilburn 3
Lanzhou 3
Lymington 3
Medicina 3
Málaga 3
Nairobi 3
Totale 6.146
Salva come PNG Salva come JPEG
Nome #
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 266
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 245
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 194
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 179
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 166
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 155
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 148
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 143
Uric acid and coronary artery disease: An elusive link deserving further attention 142
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 142
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 138
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 137
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 137
Fractional flow reserve: Current applications and overview of the available data 134
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 134
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 131
Reperfusion Damage - A Story of Success, Failure, and Hope 131
Can we improve myocardial protection during ischaemic injury? 129
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 127
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 125
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 124
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 123
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 120
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 120
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 119
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 116
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 112
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 112
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 111
Fractional flow reserve implementation in daily clinical practice: A European survey 110
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 108
BRS implantation in long lesions requiring device overlapping: Myth or reality? 108
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis 107
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 107
Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network 104
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents. 102
Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system 101
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter “real-world” registry 99
The impact of the 3-year ABSORB II trial results on my clinical practice: An Italian survey 99
Transradial coronary catheterization and intervention across the whole spectrum of Allen test results 97
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 95
null 94
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 92
Angina and left ventricular dysfunction: can we "reduce' it? 92
Remodelling after an Infarct: Crosstalk between Life and Death 88
Angina and chronic obstructive pulmonary disease: facing the perfect storm 87
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 83
Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis: A PRODIGY Trial Substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) 81
Seven french radial artery access for PCI: A prospective single-center experience 81
Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease 78
Enhanced stent visualization systems during PCI: A case series and review of literature 75
Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies 73
Meta-Analyses on DAPT Length: Chasing the Calm After the (Perfect) Storm 72
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 71
Functional Assessment and Acute Coronary Syndrome 70
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU (Gauging coronary Healing with bioresorbable Scaffolding plaTforms in EUrope) Registry 68
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 67
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 67
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 66
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 66
Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty: A Pilot Study 65
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 63
Index of microcirculatory resistance assessment in patients with new diagnosis of left ventricular dilatation without significant coronary artery lesions: IMPAIRED pilot trial 62
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 59
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 57
Extracorporeal Circulatory Support in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis 55
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials 55
Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study 53
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 46
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty 45
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study) 41
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 41
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction 38
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 35
Age and Outcomes in TAVR Patients: Are We Barking Up the Wrong Tree? 35
Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19 35
Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy 33
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 33
Frailty in patients admitted to hospital for acute coronary syndrome: when, how and why? 31
Coronary Physiology Guidance vs. Conventional Angiography for Optimization of Percutaneous Coronary Intervention: the AQVA II Trial 27
Comment on [Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease] 27
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison 27
Neural interfaces to monitor Interventional Cardiologists' mental workload: GAME-ON SAGA 26
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review 25
Quantitative flow ratio as a new tool for angiography-based physiological evaluation of coronary artery disease: a review 25
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial 24
Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial 24
What are the recommendations for adding novel oral anticoagulants to P2Y12-receptor inhibitors, with or without aspirin? 23
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 23
#FullPhysiology: a systematic step-by-step guide to implement intracoronary physiology in daily practice 22
Coronary Computed Tomography Angiography for the Assessment of Sirolimus-Eluting Resorbable Magnesium Scaffold 21
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial 20
Functional assessment 3.0: From wire through angio to OCT 20
Clinical Outcome of FFR-Guided Revascularization Strategy of Coronary Lesions: The HALE-BOPP Study 20
Long-term outcomes of patients treated with sirolimus-eluting resorbable magnesium scaffolds: Insights from the SHERPA-MAGIC study 19
Low FFR equal to low ischemia: Really? 19
Complete versus culprit-only strategy in older MI patients with multivessel disease 18
Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial 17
Invasive Coronary Physiology After Stent Implantation: Another Step Toward Precision Medicine 17
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment 16
Totale 8.210
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.103
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.174 0 0 0 0 139 213 195 156 175 164 79 53
2020/20211.185 63 59 53 108 69 79 66 167 62 174 192 93
2021/20221.032 104 95 78 43 46 57 56 72 45 77 123 236
2022/2023870 104 55 49 69 126 119 68 72 120 8 58 22
2023/2024891 48 67 36 19 60 147 53 95 23 59 76 208
2024/20251.234 112 104 279 237 502 0 0 0 0 0 0 0
Totale 8.427